|
J. Biol. Chem., Vol. 261, Issue 17, 7685-7689, Jun, 1986
Purification of insulin-like growth factor I receptor from human placental membranes
TR LeBon, S Jacobs, P Cuatrecasas, S Kathuria and Y Fujita-Yamaguchi
Insulin-like growth factor (IGF) I receptor was purified from Triton X-
100-solubilized human placental membranes by wheat germ agglutinin-
Sepharose chromatography followed by immunoaffinity chromatography using
alpha IR-3, a monoclonal antibody directed against the IGF-I receptor.
Purification of 3200-fold and 2800-fold was achieved from wheat germ
agglutinin-Sepharose eluates with regard to IGF-I binding and kinase
activities. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis under
reducing conditions revealed two major protein bands corresponding to the
alpha and beta subunits of the receptor, which accounted for at least 90%
of the protein content. The purified receptor bound 10-20 micrograms of
IGF-I/mg of protein and was more than 95% free of contamination by insulin
receptor. It sedimented in glycerol gradients as a single species with a
sedimentation coefficient of 13.7 S and gave three protein bands with Mr =
approximately 300,000 on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis under nonreducing conditions, indicating that alpha 2 beta
2 is an intact form of the IGF-I receptor. The purified receptor, when
incubated with [gamma-32P] ATP, became phosphorylated at tyrosine residues
of its beta subunit. This was stimulated 3-fold by IGF-I. It also had
IGF-I- stimulated tyrosine kinase activity (5264 pmol of 32P
incorporated/min/mg of protein) toward a synthetic peptide corresponding to
the autophosphorylation site of pp60src. These data strongly suggest that
it is a tyrosine-specific protein kinase.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Masnikosa, A. Nikolic, and O. Nedic
Affinity Modulation of Human Placental Insulin and Insulin-Like Growth Factor Receptors by Lectins
J. Biochem.,
June 1, 2008;
143(6):
813 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Spampinato, G. Pandini, A. Iuppa, V. Trischitta, R. Vigneri, and L. Frittitta
Insulin/Insulin-Like Growth Factor I Hybrid Receptors Overexpression Is Not an Early Defect in Insulin-Resistant Subjects
J. Clin. Endocrinol. Metab.,
November 1, 2000;
85(11):
4219 - 4223.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Pandini, R. Vigneri, A. Costantino, F. Frasca, A. Ippolito, Y. Fujita-Yamaguchi, K. Siddle, I. D. Goldfine, and A. Belfiore
Insulin and Insulin-like Growth Factor-I (IGF-I) Receptor Overexpression in Breast Cancers Leads to Insulin/IGF-I Hybrid Receptor Overexpression: Evidence for a Second Mechanism of IGF-I Signaling
Clin. Cancer Res.,
July 1, 1999;
5(7):
1935 - 1944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hashimoto, H. Fujiwara, N. Higashihashi, T. Enjoh-Kimura, H. Terasawa, Y. Fujita-Yamaguchi, F. Inagaki, J. F. Perdue, and K.-i. Sakano
N-terminal Deletion Mutants of Insulin-like Growth Factor-II (IGF-II) Show Thr[IMAGE] and Leu[IMAGE] Important for Binding to Insulin and IGF-I Receptors and Leu[IMAGE] Critical for All IGF-II Functions
J. Biol. Chem.,
July 28, 1995;
270(30):
18013 - 18018.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|